Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis

被引：0
|
作者：
P Guglielmelli
F Biamonte
A Spolverini
L Pieri
A Isgrò
E Antonioli
A Pancrazzi
A Bosi
G Barosi
A M Vannucchi
机构：
[1] Unità Funzionale di Ematologia,Dipartimento di Area Critica
[2] Università degli Studi,undefined
[3] Istituto Toscano Tumori,undefined
[4] Unità di Epidemiologia Clinica-Centro per lo Studio della Mielofibrosi,undefined
[5] Fondazione IRCCS Policlinico San Matteo,undefined
来源：
Leukemia | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1533 / 1537
页数：4
相关论文
共 50 条
  • [21] Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele
    Anelli, Luisa
    Orsini, Paola
    Zagaria, Antonella
    Minervini, Angela
    Coccaro, Nicoletta
    Parciante, Elisa
    Minervini, Crescenzio Francesco
    Cumbo, Cosimo
    Tota, Giuseppina
    Impera, Luciana
    Conserva, Maria Rosa
    Redavid, Immacolata
    Tarantini, Francesco
    Ricco, Alessandra
    Attolico, Immacolata
    Specchia, Giorgina
    Albano, Francesco
    LEUKEMIA, 2021, 35 (02) : 619 - 622
  • [22] The ‘GGCC’ haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera
    D Olcaydu
    R C Skoda
    R Looser
    S Li
    M Cazzola
    D Pietra
    F Passamonti
    E Lippert
    S Carillo
    F Girodon
    A Vannucchi
    N S Reading
    J T Prchal
    C Ay
    I Pabinger
    H Gisslinger
    R Kralovics
    Leukemia, 2009, 23 : 1924 - 1926
  • [23] GERMLINE HOMOZYGOSITY FOR JAK2 46/1 HAPLOTYPE IS A RISK FACTOR OF DEVELOPING PRIMARY OR POST-POLYCYTHEMIA VERA/ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS
    Andrikovics, H.
    Nahajevszky, S.
    Koszarska, M.
    Meggyesi, N.
    Bors, A.
    Halm, G.
    Lueff, S.
    Lovas, N.
    Matrai, Z.
    Csomor, J.
    Rasonyi, R.
    Egyed, M.
    Varkonyi, J.
    Mikala, G.
    Sipos, A.
    Kozma, A.
    Adam, E.
    Tordai, A.
    Masszi, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 408 - 408
  • [24] The Contribution of JAK2 46/1 Haplotype in the Predisposition to Myeloproliferative Neoplasms
    Paes, Jhemerson
    Silva, George A., V
    Tarrago, Andrea M.
    de Souza Mourao, Lucivana P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [25] The Characteristics of Patients With Unprovoked Venous Thrombotic Events With JAK2 GGCC (46/1) Haplotype Treated in Tertiary Care Center in Saudi Arabia
    Alanazi, Shatha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S340 - S341
  • [26] THE ROLE OF THE JAK2 GGCC HAPLOTYPE, TET2, AND CBL IN FAMILIAL MYELOPROLIFERATIVE NEOPLAMS
    Olcaydu, D.
    Rumi, E.
    Harutyunyan, A.
    Passamonti, F.
    Pietra, D.
    Berg, T.
    Jaeger, R.
    Klampfl, T.
    Kralovics, R.
    Cazzola, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 163 - 163
  • [27] The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms
    Olcaydu, Damla
    Rumi, Elisa
    Harutyunyan, Ashot
    Passamonti, Francesco
    Pietra, Daniela
    Pascutto, Cristiana
    Berg, Tiina
    Jaeger, Roland
    Hammond, Emma
    Cazzola, Mario
    Kralovics, Robert
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 367 - 374
  • [28] JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival
    Tefferi, A.
    Lasho, T. L.
    Patnaik, M. M.
    Finke, C. M.
    Hussein, K.
    Hogan, W. J.
    Elliott, M. A.
    Litzow, M. R.
    Hanson, C. A.
    Pardanani, A.
    LEUKEMIA, 2010, 24 (01) : 105 - 109
  • [29] JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival
    A Tefferi
    T L Lasho
    M M Patnaik
    C M Finke
    K Hussein
    W J Hogan
    M A Elliott
    M R Litzow
    C A Hanson
    A Pardanani
    Leukemia, 2010, 24 : 105 - 109
  • [30] EVALUATION OF THE ASSOCIATION BETWEEN JAK2 46/1 HAPLOTYPE AND MYELOPROLIFERATIVE NEOPLASMS
    Ha, J. S.
    Park, S.
    Kim, K.
    Lee, J.
    Lee, W.
    Ryoo, N.
    Jeon, D.
    Kim, J.
    Do, Y.
    Kwon, K.
    Jung, H.
    Chung, I.
    HAEMATOLOGICA, 2014, 99 : 125 - 126
12345